石四药集团(02005)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02005 石四药集团

未开盘 12-11 16:08:03

2.990

-0.020

-0.66%

最高3.040	最低2.980	成交量212.60万
今开3.040	昨收3.010	日振幅1.99%
总市值86.86亿	流通市值86.86亿	总股本29.05亿
成交额636.61万	换手率0.07%	流通股本29.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02005","market":"HK","secType":"STK","nameCN":"石四药集团","latestPrice":2.99,"timestamp":1765440483004,"preClose":3.01,"halted":0,"volume":2126000,"delay":0,"floatShares":2905000000,"shares":2905000000,"eps":0.358192,"marketStatus":"未开盘","change":-0.02,"latestTime":"12-11 16:08:03","open":3.04,"high":3.04,"low":2.98,"amount":6366120,"amplitude":0.019934,"askPrice":2.99,"askSize":172000,"bidPrice":2.98,"bidSize":138000,"shortable":3,"etf":0,"ttmEps":0.223096,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765503000000},"marketStatusCode":0,"adr":0,"listingDate":1135008000000,"exchange":"SEHK","adjPreClose":3.01,"dividendRate":0.048495,"openAndCloseTimeList":[[1765416600000,1765425600000],[1765429200000,1765440000000]],"volumeRatio":0.5015570444406252,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02005/tweets","defaultTab":"tweets","newsList":[{"id":"2590595161","title":"石四药集团(02005)取得有关乙酰半胱氨酸注射液(25ml: 5g)的药品生产注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2590595161","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590595161?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:32","pubTimestamp":1765441978,"startTime":"0","endTime":"0","summary":"乙酰半胱氨酸注射液主要用于急性对乙酰氨基酚中毒解毒，预防或减轻其过量引起的肝脏损伤。此外，该集团已取得国家药监局有关复方醋酸钠林格注射液的药品生产注册批件，属于化学药品第3类，视同通过一致性评价。复方醋酸钠林格注射液主要用于循环血容量及组织间液减少时细胞外液的补充及代谢性酸中毒的纠正。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","LU2460026573.USD","02005"],"gpt_icon":0},{"id":"2590569815","title":"每日卖空追踪 | 石四药集团 12月10日卖空量成交18.2万股，卖空比例为5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590569815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590569815?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355426,"startTime":"0","endTime":"0","summary":"石四药集团北京时间12月10日，跌0.66%，卖空量成交18.2万股，较上一交易日减少91.05%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163533a43f9f1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163533a43f9f1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","LU2460026573.USD","02005"],"gpt_icon":0},{"id":"2590325870","title":"每日卖空追踪 | 石四药集团 12月09日卖空量成交15.8万股，卖空比例为4.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590325870","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590325870?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:30","pubTimestamp":1765269025,"startTime":"0","endTime":"0","summary":"石四药集团北京时间12月09日，跌1.3%，卖空量成交15.8万股，较上一交易日减少90.09%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209163343a72cf1d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209163343a72cf1d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2590332580","title":"石四药集团12月09日遭主力抛售53.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590332580","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590332580?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:15","pubTimestamp":1765268153,"startTime":"0","endTime":"0","summary":"12月09日, 石四药集团股价跌1.30%，报收3.03元，成交金额1477.1万元，换手率0.17%，振幅2.28%，量比0.80。石四药集团今日主力资金净流出53.0万元，上一交易日主力净流出59.8万元。该股近5个交易日下跌1.28%，主力资金累计净流出674.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出395.8万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209162140953314a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209162140953314a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02005","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"2590039134","title":"石四药集团(02005)已取得国家药监局有关左氧氟沙星滴眼液(0.488% (5ml： 24.4mg))的药品生产注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2590039134","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590039134?lang=zh_cn&edition=full","pubTime":"2025-12-09 12:10","pubTimestamp":1765253437,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石四药集团 发布公告，本集团已取得中国国家药品监督管理局有关左氧氟沙星滴眼液的药品生产注册批件，属于化学药品第4类，视同通过一致性评价。左氧氟沙星滴眼液主要用于治疗眼睑炎、睑腺炎、泪囊炎、结膜炎、睑板腺炎、角膜炎以及用于眼科围手术期的无菌化疗法。诚如本公司日期为2025年12月4日的公告所载，本集团的匹可硫酸钠原料药已获国家药监局批准登记成为在上市制剂使用的原料药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石四药集团(02005)已取得国家药监局有关左氧氟沙星滴眼液(0.488% (5ml： 24.4mg))的药品生产注册批件","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2460026573.USD","BK1191","02005"],"gpt_icon":0},{"id":"2589860329","title":"石四药集团(02005)：非奈利酮获国家药监局批准登记成为在上市制剂使用的原料药","url":"https://stock-news.laohu8.com/highlight/detail?id=2589860329","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589860329?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:37","pubTimestamp":1764923850,"startTime":"0","endTime":"0","summary":"金吾财讯 | 石四药集团(02005)公告公布，集团的非奈利酮已获中国国家药品监督管理局批准登记成为在上市制剂使用的原料药，是国内企业第二家获批。非奈利酮主要用于与2型糖尿病相关的慢性肾脏病成人患者，可降低肾小球滤过率估计值(eGFR)持续下降、终末期肾病、心血管死亡及因心力衰竭住院的风险。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"2588004905","title":"石四药集团(02005)：比拉斯汀及匹可硫酸钠获国家药监局批准登记成为在上市制剂使用的原料药","url":"https://stock-news.laohu8.com/highlight/detail?id=2588004905","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588004905?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:33","pubTimestamp":1764837203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石四药集团(02005)发布公告,本集团的比拉斯汀及匹可硫酸钠已获中国国家药品监督管理局批准登记成为在上市制剂使用的原料药。比拉斯汀主要用于荨麻疹的对症治疗，而匹可硫酸钠主要用于结肠镜等外科手术检查前的结肠清洁。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石四药集团(02005)：比拉斯汀及匹可硫酸钠获国家药监局批准登记成为在上市制剂使用的原料药","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02005","BK1191","LU2460026573.USD"],"gpt_icon":0},{"id":"2589850071","title":"每日卖空追踪 | 石四药集团 12月04日卖空量成交16.4万股，卖空比例为3.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589850071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589850071?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837028,"startTime":"0","endTime":"0","summary":"石四药集团北京时间12月04日，涨0.98%，卖空量成交16.4万股，较上一交易日减少92.88%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163346a7235847&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163346a7235847&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","BK1191","02005"],"gpt_icon":0},{"id":"1160923513","title":"石四药集团（02005）11月回购200万股并转为库藏股","url":"https://stock-news.laohu8.com/highlight/detail?id=1160923513","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160923513?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:56","pubTimestamp":1764579412,"startTime":"0","endTime":"0","summary":"石四药集团有限公司于2025年12月1日发布2025年11月股份变动月报表，报告期为2025年11月。公司法定注册资本保持在10,000,000,000股，面值每股0.02港元，总额2亿港元。截至11月末，公司已发行股份总数维持2,951,113,385股未变，其中其中2,904,913,385股在市场流通，库藏股则增至46,200,000股。本月内，公司于11月25日按每股2.9828港元回购了2,000,000股普通股并将其转为库藏，导致流通股份相应减少2,000,000股，无新增发行或注销活动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"gpt_icon":0},{"id":"2588370766","title":"每日卖空追踪 | 石四药集团 12月01日卖空量成交21.4万股，卖空比例为3.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588370766","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588370766?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577826,"startTime":"0","endTime":"0","summary":"石四药集团北京时间12月01日，涨1.63%，卖空量成交21.4万股，较上一交易日减少77.94%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116333695244883&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116333695244883&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02005","BK1191","LU2460026573.USD"],"gpt_icon":0},{"id":"2588707639","title":"石四药集团12月01日主力净流入715.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2588707639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588707639?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:16","pubTimestamp":1764576965,"startTime":"0","endTime":"0","summary":"12月01日, 石四药集团股价涨1.63%，报收3.12元，成交金额1924.0万元，换手率0.21%，振幅1.95%，量比0.99。石四药集团今日主力资金净流入715.3万元，上一交易日主力净流出0万元。该股近5个交易日上涨6.48%，主力资金累计净流入1636.0万元；近20日主力资金累计净流入679.8万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201162250a71c6a26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201162250a71c6a26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2588719348","title":"智通港股股东权益披露|12月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588719348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588719348?lang=zh_cn&edition=full","pubTime":"2025-12-01 08:05","pubTimestamp":1764547501,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，FAST RETAIL-DRS、石四药集团、LFG投资控股于2025年12月1日进行了最新股东权益披露。股票名称机构名称性质变动前持股变动后持股持股比FAST RETAIL-DRSYanai Tadashi好仓7630.54 万股7471.54 万股23.47%(最新)23.97%(前次)石四药集团曲继广好仓12.26 亿股12.27 亿股41.56%(最新)41.54%(前次)LFG投资控股黄浩麒好仓20.00 万股10.00 万股0.02%(最新)0.04%(前次)石四药集团China Pharmaceutical Company Limited好仓8.89 亿股8.89 亿股30.13%(最新)30.11%(前次)备注：持股数变动有可能因供股、合股、拆股等情况引起，请注意对照实际情况进行辨别。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4567","03938","IE00B66KJ199.SGD","IE00B7SZL793.SGD","IE00BFXG0V08.USD","BK1147","06288","DRS","BK1114","BK4187","FAST","BK4585","IE00B5TLWC47.USD","02005","IE00B19Z4B17.USD","BK4104","BK1191","BK4588","IE00BYQQ9H92.USD","BK1502","IE0031619046.USD","LU2460026573.USD"],"gpt_icon":0},{"id":"2587732128","title":"每日卖空追踪 | 石四药集团 11月28日卖空量成交7.6万股，卖空比例为3.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587732128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587732128?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:30","pubTimestamp":1764318624,"startTime":"0","endTime":"0","summary":"石四药集团北京时间11月28日，股价较前一交易日持平，卖空量成交7.6万股，较上一交易日减少95.13%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164314a7171f3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164314a7171f3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02005","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"2587732127","title":"石四药集团维生素A原料药获批上市，拓展市场空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2587732127","media":"览富财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587732127?lang=zh_cn&edition=full","pubTime":"2025-11-28 13:53","pubTimestamp":1764309197,"startTime":"0","endTime":"0","summary":"览富财经网讯：11月27日， 石四药集团发布公告，宣布其研发的维生素A棕榈酸酯获得中国国家药品监督管理局批准，登记成为在上市制剂中使用的原料药。市场分析认为，此次获批不仅丰富了石四药集团的产品组合，更提升了其在原料药市场的综合竞争力。此次维生素A原料药的成功获批，是石四药集团深化产业链布局、提升自主供应能力的又一成果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128135325a716c754&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128135325a716c754&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02005","BK1191","LU2460026573.USD"],"gpt_icon":0},{"id":"1192238279","title":"石四药集团 - 中国Nmpa批准托特罗定酒石酸盐缓释胶囊的生产和注册","url":"https://stock-news.laohu8.com/highlight/detail?id=1192238279","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192238279?lang=zh_cn&edition=full","pubTime":"2025-11-28 12:05","pubTimestamp":1764302710,"startTime":"0","endTime":"0","summary":"石四药集团 - 中国Nmpa批准托特罗定酒石酸盐缓释胶囊的生产和注册","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2460026573.USD","BK1191","02005"],"gpt_icon":0},{"id":"2586727048","title":"石四药集团(02005)取得有关酒石酸托特罗定缓释胶囊(4mg)的药品生产注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2586727048","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586727048?lang=zh_cn&edition=full","pubTime":"2025-11-28 12:03","pubTimestamp":1764302580,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石四药集团(02005)公布，该集团已取得中国国家药品监督管理局有关酒石酸托特罗定缓释胶囊(4mg)的药品生产注册批件，属于化学药品第4类，视同通过一致性评价，是国内企业第三家获批。酒石酸托特罗定缓释胶囊主要用于治疗膀胱过度活动症。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石四药集团(02005)取得有关酒石酸托特罗定缓释胶囊(4mg)的药品生产注册批件","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2586213010","title":"石四药集团(02005)维生素 A 棕榈酸酯获批准登记成为在上市制剂使用的原料药","url":"https://stock-news.laohu8.com/highlight/detail?id=2586213010","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586213010?lang=zh_cn&edition=full","pubTime":"2025-11-27 12:02","pubTimestamp":1764216154,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石四药集团(02005)公布，该集团的维生素 A 棕榈酸酯已获中国国家药品监督管理局批准登记成为在上市制剂使用的原料药。维生素 A 棕榈酸酯主要用于脂溶性维生素注射液，补充维生素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石四药集团(02005)维生素 A 棕榈酸酯获批准登记成为在上市制剂使用的原料药","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2586132372","title":"每日卖空追踪 | 石四药集团 11月26日卖空量成交47.8万股，卖空比例为5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586132372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586132372?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:30","pubTimestamp":1764145823,"startTime":"0","endTime":"0","summary":"石四药集团北京时间11月26日，涨3.36%，卖空量成交47.8万股，较上一交易日减少82.58%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163333951b4b45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163333951b4b45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","BK1191","02005"],"gpt_icon":0},{"id":"2586213261","title":"石四药集团11月26日获主力加仓677.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586213261","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586213261?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:15","pubTimestamp":1764144927,"startTime":"0","endTime":"0","summary":"11月26日, 石四药集团股价涨3.36%，报收3.08元，成交金额2902.1万元，换手率0.33%，振幅3.36%，量比1.49。石四药集团今日主力资金净流入677.6万元，连续3日净流入，上一交易日主力净流入437.5万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为26.67%，平均涨幅为1.86%。该股近5个交易日上涨4.03%，主力资金累计净流入840.8万元；近20日主力资金累计净流入1686.9万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161739a7127ac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161739a7127ac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2586723849","title":"港股异动 | 石四药集团(02005)涨近3% 取得吲哚布芬片药品生产注册批件 心血管药物市销逐年增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2586723849","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586723849?lang=zh_cn&edition=full","pubTime":"2025-11-26 13:52","pubTimestamp":1764136376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，石四药集团涨近3%，截至发稿，涨2.68%，报3.06港元，成交额1601.14万港元。消息面上，近日，石四药集团发布公告，集团已取得中国国家药品监督管理局有关吲哚布芬片的药品生产注册批件，属于化学药品第3类，视同通过一致性评价。据摩熵医药数据库显示，吲哚布芬片2022年全终端医院销售额破10亿，近三年逐年增长，2024年超19亿，同比增37.47%，2025年上半年超11亿，同比增28.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02005","LU2460026573.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssygroup.com.hk","stockEarnings":[{"period":"1week","weight":-0.0355},{"period":"1month","weight":-0.0538},{"period":"3month","weight":-0.0478},{"period":"6month","weight":0.0444},{"period":"1year","weight":-0.1252},{"period":"ytd","weight":-0.1203}],"compareEarnings":[{"period":"1week","weight":-0.0156},{"period":"1month","weight":-0.0437},{"period":"3month","weight":-0.0325},{"period":"6month","weight":0.0686},{"period":"1year","weight":0.2667},{"period":"ytd","weight":0.2727}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石四药集团有限公司,前称为利君国际医药（控股）有限公司，是一家主要从事研究、开发、制造及向医院及分销商销售药物产品的投资控股公司。公司的产品主要包括静脉输液的成药、原料药及医用材料。该公司的产品主要包括非聚氯乙烯软袋输液、聚丙烯塑瓶输液和玻璃瓶输液。该公司的产品还包括盐酸倍他司汀、盐酸氨溴索、盐酸罗哌卡因和多索茶碱以及原料药，包括咖啡因、茶碱、氨茶碱、甲硝唑和硝苯地平。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.006433},{"month":2,"riseRate":0.55,"avgChangeRate":0.025906},{"month":3,"riseRate":0.7,"avgChangeRate":0.087461},{"month":4,"riseRate":0.5,"avgChangeRate":0.035812},{"month":5,"riseRate":0.45,"avgChangeRate":0.00985},{"month":6,"riseRate":0.5,"avgChangeRate":0.067908},{"month":7,"riseRate":0.35,"avgChangeRate":-0.027819},{"month":8,"riseRate":0.35,"avgChangeRate":-0.017769},{"month":9,"riseRate":0.3,"avgChangeRate":-0.04678},{"month":10,"riseRate":0.45,"avgChangeRate":-0.001982},{"month":11,"riseRate":0.65,"avgChangeRate":0.086372},{"month":12,"riseRate":0.5,"avgChangeRate":-0.006563}],"exchange":"SEHK","name":"石四药集团","nameEN":"SSY GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石四药集团(02005)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石四药集团(02005)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石四药集团,02005,石四药集团股票,石四药集团股票老虎,石四药集团股票老虎国际,石四药集团行情,石四药集团股票行情,石四药集团股价,石四药集团股市,石四药集团股票价格,石四药集团股票交易,石四药集团股票购买,石四药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石四药集团(02005)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石四药集团(02005)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}